Clinical Trial: Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title:

Brief Summary: Prospective, randomized non-blinded, controlled study to assess the feasibility of the CytoSorb as an adjunct to the standard of care in patients with rhabdomyolysis requiring renal replacement therapy.

Detailed Summary:
Sponsor: CytoSorbents, Inc

Current Primary Outcome:

• Efficacy of device as measured by change in myoglobin [ Time Frame: 30 days ]
• Assessment of serious device or procedure-related adverse events [ Time Frame: 30 days ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: CytoSorbents, Inc

Dates:
Date Received: March 19, 2014
Date Started: March 2014
Date Completion:
Last Updated: June 22, 2015
Last Verified: June 2015